This page may not work correctly in your current browser, Internet Explorer. We recommend changing to a more modern browser before viewing this page. We recommend Chrome, Firefox, Safari, or Edge.
News Posts List
ASCO GU 2019: First-line Pembrolizumab Monotherapy for Advanced Non-Clear Cell Renal Cell Carcinoma: Results from KEYNOTE-427 Cohort B
02/19/2019
Leaving this Page
You are about to be redirected to another portal to manage your Peer-to-Peer Fundraising pages. You can return to this portal at any time.